Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Potential regulation of kynurenine pathway metabolism by the galantamine-memantine combination in rheumatologic diseases: A hypothesis-driven review.

The Journal of pharmacology and experimental therapeutics·2026
Same author

Bupropion-Memantine Combination in the Treatment of Major Depressive Disorder and Treatment-Resistant Depression.

Human psychopharmacology·2026
Same author

Cefepime Alleviates Comorbid Pain and Depression Induced by Lipopolysaccharide in Female Mice.

Brain sciences·2026
Same author

Sequential chelator-assisted extraction and FeCl<sub>3</sub>/CaO-induced immobilization of hexavalent chromium from contaminated soil and fly ash.

Environmental research·2026
Same author

Dithiocarbamate-modified cellulose-assisted ternary coagulation-flocculation system for selective removal of arsenite and multiple heavy metals from aquatic environments.

Journal of hazardous materials·2026
Same author

Beta-lactam Antibiotic Cefepime Attenuates Lipopolysaccharide-induced Pain and Depression By Modulating Inflammatory Response and Astroglial Glutamate Transporter in Mice.

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology·2026

Related Experiment Video

Updated: Jun 10, 2026

Flypub To Study Ethanol Induced Behavioral Disinhibition and Sensitization
08:13

Flypub To Study Ethanol Induced Behavioral Disinhibition and Sensitization

Published on: May 18, 2020

Nicotinic ligands modulate ethanol-induced dopamine function in mice.

Ravi K Sajja1, Chandradhar Dwivedi, Shafiqur Rahman

  • 1Department of Pharmaceutical Sciences, College of Pharmacy, South Dakota State University, Brookings, S. Dak. 57007, USA.

Pharmacology
|August 18, 2010
PubMed
Summary
This summary is machine-generated.

Lobeline and cytisine, acting on nicotinic acetylcholine receptors, reduce ethanol

More Related Videos

An Inexpensive, Scalable Behavioral Assay for Measuring Ethanol Sedation Sensitivity and Rapid Tolerance in Drosophila
07:28

An Inexpensive, Scalable Behavioral Assay for Measuring Ethanol Sedation Sensitivity and Rapid Tolerance in Drosophila

Published on: April 15, 2015

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
05:12

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

Related Experiment Videos

Last Updated: Jun 10, 2026

Flypub To Study Ethanol Induced Behavioral Disinhibition and Sensitization
08:13

Flypub To Study Ethanol Induced Behavioral Disinhibition and Sensitization

Published on: May 18, 2020

An Inexpensive, Scalable Behavioral Assay for Measuring Ethanol Sedation Sensitivity and Rapid Tolerance in Drosophila
07:28

An Inexpensive, Scalable Behavioral Assay for Measuring Ethanol Sedation Sensitivity and Rapid Tolerance in Drosophila

Published on: April 15, 2015

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
05:12

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

Area of Science:

  • Neuroscience
  • Pharmacology
  • Neurochemistry

Background:

  • Ethanol consumption affects dopamine (DA) signaling in the brain's reward pathways.
  • Neuronal nicotinic acetylcholine receptors (nAChRs) are implicated in modulating the effects of ethanol.
  • The ventral striatum is a key brain region involved in reward and addiction.

Purpose of the Study:

  • To investigate the impact of lobeline and cytisine on ethanol-induced dopamine function in the mouse ventral striatum.
  • To determine if these nicotinic acetylcholine receptor ligands can modulate ethanol's effects on dopamine and its metabolite, dihydroxyphenylacetic acid (DOPAC).

Main Methods:

  • Utilized an ex vivo assay combined with high-performance liquid chromatography and electrochemical detection.
  • Administered acute ethanol (2.5 g/kg) systemically to C57BL/6J mice.
  • Examined the effects of pretreatment with lobeline and cytisine at various doses on ventral striatal DA and DOPAC levels.

Main Results:

  • Acute ethanol administration significantly increased dopamine and DOPAC content in the ventral striatum.
  • Pretreatment with lobeline (1 or 10 mg/kg) dose-dependently inhibited the ethanol-induced rise in DA and DOPAC.
  • Cytisine (0.5 or 3 mg/kg) also significantly reduced the ethanol-induced increase in ventral striatal DA and DOPAC levels.
  • Neither lobeline nor cytisine alone affected basal DA or DOPAC content.

Conclusions:

  • Lobeline and cytisine effectively modulate acute ethanol-induced dopamine function in the ventral striatum.
  • These findings suggest that targeting nicotinic acetylcholine receptors with these ligands can attenuate ethanol's neurochemical effects in reward circuitry.
  • Lobeline and cytisine show potential as therapeutic agents for managing ethanol dependence by influencing dopamine pathways.